Immunic, Inc. (IMUX)

Immunic Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	127	68	55	251	317	98
Market Cap Growth	79.42%	23.20%	-78.12%	-20.70%	222.80%	1143.25%
Enterprise Value	30	22	-60	165	190	69
PE Ratio	-	-0.72	-0.46	-2.70	-7.20	-2.81
PB Ratio	1.52	2.34	0.48	1.98	2.00	1.68
P/FCF Ratio	-1.57	-0.95	-0.84	-3.02	-6.85	-3.44
P/OCF Ratio	-1.58	-0.96	-0.84	-3.02	-6.87	-3.44
EV/EBITDA Ratio	-0.22	-0.23	0.50	-1.78	-4.32	-1.99
EV/EBIT Ratio	-0.22	-0.23	0.50	-1.77	-4.32	-1.98
EV/FCF Ratio	-0.29	-0.30	0.93	-1.98	-4.11	-2.43
Debt / Equity Ratio	0.01	0.02	0.01	0.00	0.00	0.01
Debt / EBITDA Ratio	0.00	-0.01	-0.01	-0.01	-0.02	-0.01
Debt / FCF Ratio	-0.01	-0.01	-0.02	-0.01	-0.01	-0.02
Quick Ratio	4.83	1.89	8.90	7.62	15.18	4.15
Current Ratio	5.09	2.12	9.63	9.21	15.93	4.56
Return on Equity (ROE)	-170.20%	-157.40%	-98.60%	-70.00%	-39.10%	-70.80%
Return on Assets (ROA)	-124.70%	-117.40%	-89.60%	-63.40%	-36.40%	-64.50%
Return on Capital (ROIC)	-114.10%	-335.55%	-104.20%	-71.78%	-30.71%	-62.89%
Earnings Yield	-77.10%	-138.24%	-219.06%	-37.00%	-13.89%	-35.60%
FCF Yield	-59.48%	-105.09%	-118.72%	-33.16%	-14.61%	-29.10%
Buyback Yield / Dilution	-122.83%	-39.29%	-34.53%	-51.00%	-102.84%	-811.77%
Total Shareholder Return	-122.83%	-39.29%	-34.53%	-51.00%	-102.84%	-811.77%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).